Physician profile
Sandeep Sagar
NPI 1861550386
$9,247.15
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $1,253 · 2021: $110 · 2022: $6,032 · 2023: $342 · 2024: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034 · Travel and Lodging: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.27 |
| Travel and Lodging | $135.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,643.24 | 2020-2023 | Amvia Edge, Biomonitor |
| Abbott Laboratories | $2,239.04 | 2019-2024 | Aveir, Jot Dx |
| Cardiofocus, INC. | $850.71 | 2022 | |
| Atricure, INC. | $401.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $288.06 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $274.82 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.19 | 2022-2024 | Jardiance |
| Biosense Webster, INC. | $195.10 | 2020-2024 | Carto 3, Qdot Micro Catheter |
| Amgen INC. | $162.09 | 2021-2024 | Repatha |
| Boston Scientific Corporation | $150.57 | 2019-2023 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.59 | 2022-2024 | Lifevest |
| Esperion Therapeutics, INC. | $109.94 | 2021-2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $93.52 | 2022-2024 | Eliquis, Camzyos |
| Pfizer INC. | $92.88 | 2021-2024 | |
| Lexicon Pharmaceuticals, INC. | $77.19 | 2023-2024 | Inpefa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $56.44 | 2022-2024 | Verquvo |
| Elutia, INC. | $51.78 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $45.44 | 2022-2023 | |
| Medtronic Vascular, INC. | $30.29 | 2020 | |
| Chiesi USA, INC. | $23.90 | 2023 | Kengreal, Cleviprex |
| Zoll Circulation INC | $22.50 | 2022 | |
| Cardiva Medical, INC. | $20.14 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Terumo Medical Corporation | $19.28 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $19.27 | 2024 | Brilinta |
| Actelion Pharmaceuticals US, INC. | $17.12 | 2023 | Opsumit, Uptravi |
| Philips North America LLC | $15.83 | 2020 | |
| Medtronic, INC. | $15.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Sagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.